LATEST ALERTSThe UK Medicines and Healthcare Products Regulatory Agency has drawn a clear line on CBD’s medical claims. Meanwhile, the Food Standards Agency has softened its stance on allowable levels of THC in food
Barnaby Page, host of Tamarind Intelligence podcast, sits down with Michael Landl, director of the World Vapers’ Alliance, to unpack the major regulatory hurdles facing the e-cigarette sector in 2025 and beyond
Join our host Barnaby Page as he sits down with Pablo Cano Trilla, regulatory director at Tamarind Intelligence, to explore the latest global updates on novel nicotine regulation.
On the surface, 2024 could seem like a disappointing year for commercial cannabinoids, but scratch the surface and it really was not all that bad
Join the Tamarind Intelligence leadership team for a compelling round-table discussion with four top industry experts. They’ll reflect on the major moments of 2024 in the reduced-risk nicotine world and share their insights for 2025.
Permitted THC levels in CBD products in the UK will be below Home Office drug law levels, according to the Food Standards Agency (FSA), though a specific amount has not been announced
This report offers a detailed analysis of the current regulatory framework in place in Spain for hemp, CBD and other cannabinoids, as well medical and recreational cannabis
The UK Food Standards Agency (FSA) board met on 11th December to discuss a recent report on progress towards approval of an ingestible CBD product in the country
Rupert Wilson, managing director at Strategic Business Consulting and former Rothmans International tobacco expert, sits down with Tamarind Intelligence’s Tim Phillips to examine the influence of novel nicotine products on the performance and strategic direction of public tobacco firms.
Join Tamarind Intelligence founder Tim Phillips and Editorial Director Barnaby Page as they explore the complexities of the illicit e-cigarette trade.
Some fear healthcare and food safety will not be among the main concerns of the next European Commission after the Commission president unveiled the new commissioners’ respective tasks
Clinical trials on CBD-based medical drug Epidiolex missed their main goal of registering a significant reduction in the frequency of seizures experienced by patients in Japan, based on the results reported by manufacturer Jazz Pharmaceuticals
After a few back-and-forths, Italian authorities may actually kill the country’s CBD sector by simply passing a minor amendment to a major soon-to-be-approved bill, banning hemp flower and its extracts regardless of their THC content
In June 2022, the European Food Safety Authority broke some very bad news to CBD companies applying for their products to be authorised as novel food in the European Union
UK-based CBD brands Cannaray and Pureis are the first to obtain a positive safety assessment from the Food and Standards Agency (FSA) Advisory Committee on Novel Foods and Processes
This report offers a detailed analysis of the current regulatory framework in place in Ukraine for hemp, cannabis and CBD, as well as other cannabinoids
This report examines regulatory developments in cannabis consumption and explains why CannIntelligence believes that intoxicating cannabinoid beverages have a bright future in the US
This report provides a detailed analysis of the current regulatory framework in place in Colombia for cannabis, hemp and other cannabinoids including CBD
This report provides analysis of the current regulatory framework in place in Israel for cannabis and cannabinoids, including CBD and hemp. It covers everything from cultivation and processing to finished products, extracts and import/export…
Stay up-to-date with key market trends and regulatory news and receive complimentary data on a regular basis.
"*" indicates required fields
Get 7 days of access to industry updates through our news analysis and regulatory alerts
"*" indicates required fields
